Rating History for Arcus Biosciences (RCUS) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/13/2026 | Richard Law | New Coverage | Buy (N/A) |
28.00 (N/A) |
21.01 (22.11) |
5.24% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/13/2026 | Richard Law | New Coverage | Buy (N/A) |
28.00 (N/A) |
21.01 (22.11) |
5.24% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||